Clinical Trials on Bladder Integrity in Japan
Total 69 results
-
Taiho Pharmaceutical Co., Ltd.CompletedOveractive Bladder | Detrusor UnderactivityJapan
-
Iwate Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Ono Pharmaceutical Co. LtdKyorin Pharmaceutical Co.,LtdCompletedOveractive BladderJapan
-
Iwate Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Astellas Pharma IncCompleted
-
Urological Oncology Council of Northern TokyoUnknown
-
Astellas Pharma IncCompletedOveractive BladderJapan
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveJapan
-
Kyoto UniversityTerminated
-
Eli Lilly and CompanyCompletedNon-Hodgkin's Lymphoma | Solid Tumor | Metastatic Cancer | Cholangiocarcinoma | Advanced Cancer | Biliary Tract Carcinoma | Gall Bladder CarcinomaJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Kissei Pharmaceutical Co., Ltd.Completed
-
Kissei Pharmaceutical Co., Ltd.WithdrawnOveractive BladderJapan
-
Astellas Pharma IncCompleted
-
BayerCompletedOveractive Bladder | Diabetic Neuropathic Pain | Endometriosis Related Pain | Refractory or Unexplained Chronic CoughJapan
-
Kyoto University HospitalMerck Sharp & Dohme LLC; Astellas Pharma Inc; University of Tsukuba; Kobe City... and other collaboratorsRecruiting
-
Astellas Pharma IncCompleted
-
Kissei Pharmaceutical Co., Ltd.Completed
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveJapan
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, Los Angeles; University... and other collaboratorsRecruiting
-
Astellas Pharma IncCompletedOveractive Bladder | Cardiovascular DiseaseJapan
-
Astellas Pharma IncCompletedOveractive Bladder | Benign Prostatic Hyperplasia | Benign Prostatic HypertrophyJapan
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, San Francisco; Fred... and other collaboratorsActive, not recruitingBladder CancerUnited States, Japan
-
Janssen Pharmaceutical K.K.RecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorJapan
-
Nippon Kayaku Co., Ltd.Handok Inc.TerminatedBladder CancerJapan, Korea, Republic of
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, Los Angeles; Fred... and other collaboratorsRecruitingBladder CancerUnited States, Japan
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, Los Angeles; University... and other collaboratorsRecruitingBladder CancerUnited States, Japan
-
Astellas Pharma IncAstellas Pharma Singapore Pte. Ltd.Completed
-
GlaxoSmithKlineCompletedUrinary Bladder, OveractiveJapan
-
PfizerCompletedUrinary Bladder, NeurogenicJapan
-
GlaxoSmithKlineRecruiting
-
PfizerCompleted
-
Astellas Pharma Europe B.V.CompletedUnderactive BladderJapan, Poland, Germany, Netherlands, Slovakia, United Kingdom
-
GlaxoSmithKlineCompletedUrinary Bladder, OveractiveJapan
-
CG Oncology, Inc.RecruitingNon Muscle Invasive Bladder Cancer | High-grade Ta/ T1 Papillary Disease Bladder CancerUnited States, Korea, Republic of, Taiwan, Japan, Australia
-
Ferring PharmaceuticalsRecruiting
-
Ono Pharmaceutical Co. LtdCompleted
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder NeoplasmsKorea, Republic of, United States, United Kingdom, China, Japan, Brazil, Argentina
-
BayerCompletedCystitis / Pyelonephritis / Cystic Fibrosis / AnthraxJapan
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands
-
PfizerCompletedOveractive BladderKorea, Republic of, Taiwan, Hong Kong, Japan
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
PfizerCompletedUrinary Bladder, NeurogenicFrance, United States, Spain, Korea, Republic of, United Kingdom, Malaysia, Taiwan, Finland, Japan, Lithuania, Italy, Turkey, Estonia, Slovakia, Belgium, Canada, Germany, Greece, India, Philippines, Poland, Russian Federation, South... and more
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerUnited States, Belgium, France, Germany, Italy, Spain, United Kingdom, Canada, Poland, Taiwan, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, Japan, Philippines, Israel, Chile, Australia, Netherlands, Russian Federation
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Colombia, ... and more
-
Hoffmann-La RocheRecruitingMuscle-invasive Bladder CancerBelgium, Korea, Republic of, Japan, Brazil, China, United States, Singapore, France, United Kingdom, Canada, Greece, Italy, Spain, Turkey, Russian Federation, Ukraine, Israel, Czechia, Colombia, Hong Kong, Argentina, Germany, Ireland, Polan... and more
-
AstraZenecaRecruitingMuscle Invasive Bladder CancerNetherlands, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Poland, Spain, Turkey, Vietnam, Argentina, Japan, France, Brazil, Taiwan, United States, Israel, Austria, Chile, Colombia, Greece, Hong Kong, Mexico, Portugal, Russian... and more
-
PfizerActive, not recruitingNon-muscle Invasive Bladder CancerChina, United States, Spain, Belgium, Korea, Republic of, Australia, United Kingdom, Japan, France, Germany, Canada, Russian Federation, Poland, Italy